Simplex Trading, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$143.31 - $247.0 $1.26 Million - $2.17 Million	8,803 New	8,803 $2.14 Million
Q4 2023 Feb 02, 2024	SELL	$151.41 - $196.57 $594,889 - $772,323	-3,929 Reduced 57.4%	2,916 $558,000
Q3 2023 Nov 01, 2023	BUY	$170.77 - $211.65 $1.17 Million - $1.45 Million	6,845 New	6,845 $1.21 Million
Q1 2023 Apr 27, 2023	BUY	$182.66 - $235.53 $885,170 - $1.14 Million	4,846 Added 54.59%	13,723 $2.75 Million
Q4 2022 Feb 02, 2023	BUY	$185.53 - $241.31 $1.65 Million - $2.14 Million	8,868 Added 98533.33%	8,877 $2.11 Million
Q3 2022 Nov 04, 2022	SELL	$138.54 - $232.0 $147,960 - $247,776	-1,068 Reduced 99.16%	9 $1,000
Q2 2022 Aug 03, 2022	SELL	$120.42 - $169.29 $1.8 Million - $2.52 Million	-14,914 Reduced 93.26%	1,077 $157,000
Q3 2021 Oct 28, 2021	BUY	$169.75 - $207.73 $120,013 - $146,865	707 Added 4.63%	15,991 $2.71 Million
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $115,509 - $158,847	898 Added 6.24%	15,284 $2.59 Million
Q1 2021 Apr 26, 2021	BUY	$126.83 - $175.69 $800,424 - $1.11 Million	6,311 Added 78.15%	14,386 $2.03 Million
Q4 2020 Feb 02, 2021	BUY	$122.97 - $147.0 $959,903 - $1.15 Million	7,806 Added 2901.86%	8,075 $1.05 Million
Q3 2020 Oct 14, 2020	BUY	$121.19 - $165.49 $32,600 - $44,516	269 New	269 $39,000
Q2 2020 Jul 13, 2020	SELL	$104.21 - $156.44 $1.51 Million - $2.26 Million	-14,470 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$93.12 - $133.99 $1.35 Million - $1.94 Million	14,470 New	14,470 $1.58 Million
Q2 2019 Jul 26, 2019	SELL	$65.86 - $92.79 $182,563 - $257,213	-2,772 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$72.76 - $93.45 $201,690 - $259,043	2,772 New	2,772 $0
Q1 2018 Apr 26, 2018	SELL	$115.92 - $148.54 $692,158 - $886,932	-5,971 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$114.49 - $139.98 $735,369 - $899,091	-6,423 Reduced 51.82%	5,971 $758,000
Q3 2017 Oct 25, 2017	BUY	$72.53 - $118.27 $898,936 - $1.47 Million	12,394	12,394 $1.46 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.2 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.21 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.43 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.33 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.26 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account